Neurodegenerative Diseases: current treatment algorithm and potential investment opportunities covered in a lates research report

This report examines the entire neurodegenerative disease therapy area, with a particular focus on the three most prevalent neurodegenerative disorders: Alzheimer’s disease (AD), Parkinson’s disease (PD) and multiple sclerosis (MS).

Pune, India - March 14, 2018 /MarketersMedia/ —

AD and PD represent the most pressing challenges within the disease cluster, due to rapidly increasing prevalence driven by aging populations. Both AD and PD remain ineffectively treated despite substantial investment into R&D by pharmaceutical companies, due to high clinical trial failure rates. As a result there are no disease-modifying therapies for these two indications, with available treatments able to provide only marginal symptomatic relief. MS, the autoimmune disease of the CNS, contrasts with the rest of this cluster, as it affects a different population demographic, and has a lucrative pharmacological market following breakthrough success in the past decade.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-neurodegenerative-diseases-protein-misfolding-targets-and-neuromodulators-dominate-the-first-in-class-pipeline-and-lead-the-way-as-potential-disease-modifying-therapies-in-ad-and-pd
Reasons To Buy
• Appreciate the current clinical and commercial landscapes by considering disease symptoms, pathogenesis, etiology, co-morbidities and complications, epidemiology, diagnosis, prognosis and treatment options.
• Identify leading products and key unmet needs within the market.
• Recognize innovative pipeline trends by analyzing therapies by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using proprietary matrix assessments, first-in-class targets in the pipeline have been assessed and ranked according to clinical potential. Individual matrix assessments are provided for targets categorized into four major classes: protein misfolding, neuromodulators, immunomodulators and neuroprotectants. The most promising first-in-class targets are reviewed in greater detail.
• Consider first-in-class pipeline products with no prior involvement in licensing and co-development deals, which may represent potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/935553
Scope
• Unmet need is extremely high in AD and PD, with MS showing continued promise in the development of effective therapies
• What are the most important etiological risk factors and pathophysiological processes implicated in AD, PD and MS?
• What is the current treatment algorithm?
• How effective are current therapies for these indications, and how does this impact prognosis?
• The AD pipeline is large and contains a very high proportion of first-in-class product innovation.
• Which molecule types and molecular targets are most prominent across AD, PD and MS?
• What are the connections, in terms of first-in-class innovation, between AD, PD and MS?
• Which first-in-class targets are most promising?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935553

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/neurodegenerative-diseases-current-treatment-algorithm-and-potential-investment-opportunities-covered-in-a-lates-research-report/314330

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-neurodegenerative-diseases-protein-misfolding-targets-and-neuromodulators-dominate-the-first-in-class-pipeline-and-lead-the-way-as-potential-disease-modifying-therapies-in-ad-and-pd%20

Source: MarketersMedia

Release ID: 314330

More Press Releases

Stocks, bond yields fall sharply as growth worries spread

Mar 23, 2019

Wall Street was roiled Friday by new signs that global economic growth is slowing. The jitters triggered a sell-off in stocks and sent bond yields sharply lower, flashing a possible recession warning. The wave of selling knocked 460 points off the Dow Jones Industrial Average and gave the benchmark S&P 500 index its worst day since Jan. 3. The Russell 2000 index of smaller company stocks fell more than the rest of the market as traders offloaded risker assets. Worried investors shifted money into bonds, which sent yields much lower. The yield on the 10-year Treasury dropped to 2.43 percent...

Markets Right Now: Stocks, yields drop on growth worries

Mar 23, 2019

NEW YORK — The latest on developments in financial markets (all times local): 4 p.m. Stocks closed broadly lower on Wall Street, erasing their gains for the week, as investors became increasingly worried that the global economy is slowing down. Traders shifted money into bonds and other low-risk assets Friday. Bond yields fell sharply, hurting bank stocks and flashing a possible recession warning. Citigroup slumped 4.6 percent. Boeing fell 2.8 percent after Indonesia's flag carrier said it would seek to cancel an order of the company's planes. The S&P 500 fell 54 points, or 1.9 percent, to 2,800. The Dow...

Trump to nominate conservative Stephen Moore for Fed board

Mar 23, 2019

WASHINGTON — President Donald Trump said Friday that he will nominate Stephen Moore, a conservative economic analyst and frequent critic of the Federal Reserve, to fill a vacancy on the Fed's seven-member board. Moore, a well-known and often polarizing figure in Washington political circles, served as an adviser to Trump during the 2016 campaign. In that role, he helped draft Trump's tax cut plan. Trump has been harshly critical of the Fed's rate increases even after the central bank announced this week that it foresees no hikes this year. Moore, formerly chief economist for the conservative Heritage Foundation, has also...

Italy, China deepen ties under wary gaze of US, EU

Mar 23, 2019

MILAN — Italy's head of state told visiting Chinese President Xi Jinping on Friday that China's new "Silk Road" linking Europe and Asia must be a "two-way street," addressing concerns among Western allies that the colossal infrastructure project is meant merely to amplify Beijing's global influence. During Xi's two-day official state visit, Italy is expected to become the first major democracy to sign an agreement to join China's "Belt and Road" initiative. The program aims to invest in ports, roads, airports and railways in Asia, Africa and Europe to create a conduit for trade and China's construction industry. Both the...

Stocks fall on growth worries, Brexit doubts

Mar 23, 2019

SINGAPORE — Stocks fell sharply in Europe on Friday after surveys showed manufacturing in the region slowed in March and amid news that the European Union offered only a brief extension to the Brexit deadline. U.S. markets also appeared headed for a lower open. Britain's FTSE 100 led the decline, trading down 1.3 percent at 7,260, while the CAC 40 in France slid 1.2 percent to 5,315. Germany's DAX lost 0.7 percent to 11,467. The future contract for the Dow Jones Industrial Average was 0.7 percent lower at 25,828. That for the broad S&P 500 index also lost 0.7 percent,...

Subscribe to our newsletter!

Your Name

Your Email Address